Reviews on Recent Clinical Trials

Scope & Guideline

Exploring Innovations in Therapeutic Strategies.

Introduction

Welcome to your portal for understanding Reviews on Recent Clinical Trials, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1574-8871
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2006 to 2024
AbbreviationREV RECENT CLIN TRIA / Rev. Recent Clin. Trials
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

The journal 'Reviews on Recent Clinical Trials' is dedicated to providing comprehensive insights into clinical trials across various medical specialties. It aims to bridge the gap between research findings and practical applications in clinical settings, emphasizing rigorous methodologies and innovative treatments.
  1. Clinical Trial Methodology:
    The journal focuses on the design, implementation, and analysis of clinical trials, including randomized controlled trials, observational studies, and systematic reviews.
  2. Emerging Therapeutics and Interventions:
    It covers research on new drugs, therapies, and treatment protocols, highlighting their efficacy and safety in diverse patient populations.
  3. Disease-Specific Studies:
    The journal emphasizes studies that address specific diseases, providing insights into clinical outcomes, patient demographics, and tailored treatment approaches.
  4. Public Health and Epidemiology:
    It includes research on public health implications of clinical findings, particularly in the context of infectious diseases and chronic conditions.
  5. Patient-Centered Outcomes:
    The journal values research that assesses patient-reported outcomes and quality of life, ensuring that the patient's perspective is integral to clinical trial evaluations.
In recent years, 'Reviews on Recent Clinical Trials' has seen a rise in interest in several emerging themes that reflect the evolving landscape of clinical research. These trending topics not only highlight current health challenges but also showcase innovative approaches to treatment and patient care.
  1. COVID-19 Related Research:
    There is a significant increase in studies related to COVID-19, including vaccine efficacy, treatment protocols, and long-term effects of the virus, reflecting the ongoing global health crisis.
  2. Integrative and Complementary Therapies:
    Emerging interest in the efficacy of integrative and complementary therapies, such as herbal medicine and nutraceuticals, is rising, as researchers explore holistic approaches to treatment.
  3. Personalized Medicine:
    The trend towards personalized medicine, which tailors treatment based on individual patient characteristics, is gaining momentum, particularly in oncology and chronic disease management.
  4. Mental Health in Chronic Illness:
    An increasing focus on the intersection of mental health and chronic illnesses is evident, underscoring the importance of addressing psychological well-being in treatment plans.
  5. Telemedicine and Remote Patient Monitoring:
    With the growth of digital health, studies exploring the efficacy and implementation of telemedicine and remote monitoring systems are becoming more prevalent, especially post-pandemic.

Declining or Waning

While 'Reviews on Recent Clinical Trials' continues to explore a wide array of topics, certain themes have shown a decline in frequency and relevance in recent publications. These waning scopes may reflect shifting priorities in clinical research and emerging interests in more pressing health concerns.
  1. Traditional Treatment Modalities:
    There has been a noticeable decline in studies focusing on conventional treatment methods, as newer therapies and innovative approaches gain traction in clinical research.
  2. Generalized Health Assessments:
    Research that broadly assesses health outcomes without a specific focus on clinical trials or interventions appears to be decreasing, as the journal shifts towards more targeted studies.
  3. Longitudinal Studies without Intervention:
    Longitudinal observational studies that do not involve direct interventions or trials are becoming less frequent, possibly as researchers seek more actionable insights.
  4. Pharmacological Reviews of Established Drugs:
    The journal is moving away from extensive reviews of well-established drugs in favor of novel therapeutics, reflecting a trend towards innovation rather than reiteration.
  5. Non-Clinical Research Topics:
    There is a waning interest in non-clinical topics, such as basic science or preclinical research, as the focus remains on clinical implications and applications.

Similar Journals

Modern Rheumatology

Navigating the Frontiers of Rheumatology
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Open Access Journal of Clinical Trials

Elevating Pharmacology Research to New Heights.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-1519Frequency: 1 issue/year

Open Access Journal of Clinical Trials is a premier peer-reviewed journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of clinical pharmacology and medical research. With an impactful open access model initiated in 2009, this journal makes valuable research widely accessible, fulfilling the urgent need for rapid dissemination of scientific knowledge. The journal has established itself as a significant resource in its field, boasting impressive metrics with a 2023 Q2 ranking in Pharmacology (Medical) and a Q1 ranking in the Miscellaneous subsector of Pharmacology, Toxicology, and Pharmaceutics, underscoring its reputation for excellence. Based in New Zealand, the journal fosters global collaboration, and its comprehensive coverage spans various domains within pharmacology and clinical trials. Researchers and practitioners are encouraged to contribute to this vital discourse, as the journal serves as a platform for innovation, collaboration, and the exchange of groundbreaking findings in clinical trials.

Chiropractic & Manual Therapies

Pioneering Insights for Better Health Practices.
Publisher: BMCISSN: Frequency: 1 issue/year

Chiropractic & Manual Therapies is a premier open-access journal published by BMC, dedicated to advancing the fields of Chiropractic, Complementary and Alternative Medicine, and Physical Therapy. Since its inception in 2011, the journal has established its reputation within the academic community, evidenced by its Q1 ranking in Chiropractics and Complementary and Alternative Medicine, and Q2 in Physical Therapy, Sports Therapy, and Rehabilitation as of 2023. With an impressive Scopus ranking placing it in the top 5% for Chiropractics and maintaining a strong presence in the complementary medicine sector, Chiropractic & Manual Therapies serves as a critical platform for researchers, practitioners, and students seeking to disseminate innovative findings and practical advancements in manual therapies. Located in the United Kingdom, the journal not only promotes accessible research but also contributes to the ongoing discourse in healthcare practices, ensuring valuable insights are shared widely among professionals and the academic community.

Clinics in Orthopedic Surgery

Advancing orthopedic knowledge for a healthier future.
Publisher: KOREAN ORTHOPAEDIC ASSOCISSN: 2005-291XFrequency: 4 issues/year

Clinics in Orthopedic Surgery is a premier open-access journal dedicated to advancing the field of orthopedics, published by the Korean Orthopaedic Association. With its ISSN 2005-291X and E-ISSN 2005-4408, this journal provides a dynamic platform for disseminating high-quality research and clinical insights relevant to orthopedic surgery. Since its inception in 2009, it has established a commendable reputation within the academic community, achieving a Q1 ranking in both Orthopedics and Sports Medicine, and Surgery for 2023, as well as notable Scopus rankings. This journal not only facilitates global access to cutting-edge research but also aims to foster collaboration among researchers, professionals, and students alike. Its comprehensive scope and open-access model enhance the visibility and impact of published works, ensuring that critical advancements in orthopedic knowledge reach a wide audience. As it continues to cover diverse topics within the field through 2024 and beyond, Clinics in Orthopedic Surgery remains an essential resource for those invested in orthopedic practice and surgery.

Clinical Medicine Insights-Oncology

Empowering oncologists with cutting-edge insights.
Publisher: SAGE PUBLICATIONS LTDISSN: Frequency: 1 issue/year

Clinical Medicine Insights-Oncology is a leading journal published by SAGE Publications Ltd, focusing on the interdisciplinary aspects of oncology. With an open access model since 2007, this journal fosters the dissemination of high-quality research and clinical insights that are crucial for advancing knowledge in cancer treatment and management. Based in New Zealand, it aims to bridge gaps in current oncology practices through the publication of innovative studies, case reports, and reviews. With a respectable ranking in Scopus at #264 out of 404 journals in the oncology category and belonging to the Q3 quartile, it positions itself as a valuable resource for oncologists, researchers, and students committed to enhancing patient outcomes. This journal strives to provide a platform for groundbreaking research that can impact clinical practice and inform policy within the field of oncology.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Championing Unrestricted Access to Vital Medical Research
Publisher: SAGE PUBLICATIONS LTDISSN: 0300-0605Frequency: 12 issues/year

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, published by SAGE Publications Ltd, serves as a vital platform in the fields of biochemistry and medicine, showcasing significant research contributions since its inception in 1972. With an Open Access policy implemented in 2012, this journal promotes unrestricted dissemination of knowledge, catering to a global audience and ensuring that critical findings are accessible to researchers, healthcare professionals, and students alike. With an impressive scope spanning diverse biomedical disciplines, the journal ranks in the Q3 quartile for both biochemistry and medicine, affirming its relevance and impact within these evolving fields. Hailing from the United Kingdom, the journal is dedicated to fostering a rich academic dialogue that bridges laboratory discoveries and clinical applications, making it an essential resource for those engaged in international medical research. Its ongoing commitment to excellence is reflected in its convergence until 2024, inviting high-quality submissions that contribute to advancements in medical science.

Istanbul Medical Journal

Advancing medical knowledge for a healthier tomorrow.
Publisher: GALENOS PUBL HOUSEISSN: 2619-9793Frequency: 4 issues/year

Istanbul Medical Journal is a prominent open-access journal published by GALENOS PUBL HOUSE, dedicated to disseminating high-quality research in the field of medicine since its inception in 1994. The journal, identifiable by its ISSN 2619-9793 and E-ISSN 2148-094X, serves as a critical platform for healthcare professionals, researchers, and students who aim to share innovative studies and advancements within diverse medical domains. Its commitment to open access ensures that crucial findings and discussions are readily available to a global audience, fostering collaboration and knowledge exchange among the scientific community. Located in Istanbul, Türkiye, the journal not only contributes to the medical literature landscape but also emphasizes the importance of accessibility in research, aligning with current academic trends that prioritize the transmission of knowledge across barriers. As a resource for those involved in healthcare and medical research, the Istanbul Medical Journal plays a vital role in shaping future developments in medicine.

NEW ENGLAND JOURNAL OF MEDICINE

Bridging Research and Clinical Practice Since 1945
Publisher: MASSACHUSETTS MEDICAL SOCISSN: 0028-4793Frequency: 52 issues/year

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

Journal of Personalized Medicine

Exploring the frontiers of individualized medicine.
Publisher: MDPIISSN: Frequency: 12 issues/year

Journal of Personalized Medicine is a pioneering open-access journal published by MDPI, renowned for its commitment to advancing research in the dynamic field of personalized healthcare. Since its inception in 2011, this journal has served as a critical platform for scholars, practitioners, and students interested in the integration of individualized therapies and diagnostic techniques that aim to tailor medical treatments to the unique characteristics of each patient. With an impressive Q2 ranking in the field of medicine, as recognized by Scopus, and currently holding a percentile rank of 65th, it stands out among its peers with a focus on innovative approaches that challenge traditional paradigms. Researchers can benefit from its open-access model, allowing for broader dissemination of findings that can significantly impact clinical practices and research directions globally. Set against the picturesque backdrop of Basel, Switzerland, the journal is positioned at the forefront of medical innovation, producing high-quality, peer-reviewed articles that span the latest advancements and applications in personalized medicine.

Research in Pharmaceutical Sciences

Pioneering Insights for Safer Pharmaceuticals
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1735-5362Frequency: 6 issues/year

Research in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.